2nd June 2020

Athletics Athlete Suspended for the Presence of Clenbuterol and Tamoxifen

The Canadian Centre for Ethics in Sport (CCES) announced today that Graeme Thompson, an athletics athlete, received a two-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on July 27, 2019, revealed the presence of clenbuterol, a prohibited anabolic agent, and tamoxifen, a prohibited hormone and metabolic modulator.

In accordance with Canadian Anti-Doping Program (CADP) Rule 10.2.1, the standard sanction for the presence of the above referenced substances is a four-year period of ineligibility. However, based on information provided by the athlete, the CCES determined that the violation was not intentional and therefore proposed a sanction of two years ineligibility from sport (in accordance with CADP Rule 10.2.2).

In response to the CCES’s notification of the adverse analytical finding, Mr. Thompson waived his right to a hearing and accepted the proposed sanction, which terminates on October 9, 2021. During the sanction period, the athlete, who resides in Port Hope, ON, is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates. In compliance with rule 7.10 of the CADP, the CCES’s file outcome summary can be found in the Canadian Sport Sanction Registry.

• This media release was published by the Canadian Centre for Ethics in Sport (CCES) on 2 June 2020. Click here for the original.

You may also like...

Pin It on Pinterest

Share This